# PRCXI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prcxi

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.prcxi.com
- Total disclosed funding: $14M
- Latest round: Series A (Dec 31, 2025)
- Investors on record: 5

## About

Based in Suzhou, China, and founded in 2020, Suzhou Zhongxi Biological Information Co., Ltd., dba PRCXI, is a medical company that provides automation solutions in the field of life sciences. The branches were set up in Guangzhou, Xiamen, Hangzhou, and other places. The company has established partnerships with more than 800 laboratories such as Bio-Thera, Tsinghua University, Sinopharm, etc. In December 2020, it was awarded the title of the third batch of Dongwu Science and Technology Innovation and Entrepreneurship Leaders. In November 2021, the fully automated sequencing pre-processing system was developed. In April 2024, PRCXI closed a pre-series A++ funding. As of 2024, the team has more than 120 employees.  In December 2025, PRCXI closed Series A+ funding led by new investor CICC Capital.
The company is committed to developing and producing laboratory automation equipment. The products include high-precision liquid handling platforms, dividing cup systems, electrophoresis systems, and so on. It also offers technical support in automation equipment and software science, as well as an integrated solution for medical and scientific research equipment. The company generates revenue by selling laboratory automation equipment. 
The company generates revenue by selling laboratory automation equipment.

## Funding rounds

- Series A, Dec 31, 2025 — China International Capital Corporation
- Series A, Jul 1, 2025, $14M — Qiming Venture Partners, China Capital Management
- Angel, Oct 13, 2023 — Suzhou Wuzhong Rongyue Investment Management, Wuzhong Financial Holdings Capital

## Investors

- Suzhou Wuzhong Rongyue Investment Management — Angel
- Wuzhong Financial Holdings Capital (https://capitalatlas.ai/funds/wuzhong-financial-holdings-capital) — Angel
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A
- China Capital Management (https://capitalatlas.ai/funds/china-capital-management) — Series A
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series A